1. Involvement of TREK1 channels in the proliferation of human hepatic stellate LX-2 cells
- Author
-
Rubii Kondo, Akari Deguchi, Naoki Kawata, Yoshiaki Suzuki, and Hisao Yamamura
- Subjects
Liver Cirrhosis ,Pharmacology ,Proliferation ,Gene Expression ,Calcium signaling ,RM1-950 ,Collagen Type I ,Cell Line ,Membrane Potentials ,TREK1 ,Potassium Channels, Tandem Pore Domain ,Hepatic Stellate Cells ,Humans ,Molecular Medicine ,Calcium ,Two-pore domain potassium channel ,Therapeutics. Pharmacology ,Hepatic stellate cell ,Cell Proliferation - Abstract
Activation of hepatic stellate cells (HSCs) causes hepatic fibrosis and results in chronic liver diseases. Although activated HSC functions are facilitated by an increase in the cytosolic Ca2+ concentration ([Ca2+]cyt), the pathophysiological roles of ion channels are largely unknown. In the present study, functional analyses of the two-pore domain K+ (K2P) channels, which regulate the resting membrane potential and [Ca2+]cyt, were performed using the human HSC line, LX-2. Expression analyses revealed that TREK1 (also known as KCNK2 and K2P2.1) channels are expressed in LX-2 cells. Whole-cell K+ currents were activated by 10 μM arachidonic acid and the activation was abolished by 100 μM tetrapentylammonium, which are pharmacological characteristics of TREK1 channels. The siRNA knockdown of TREK1 channels caused membrane depolarization and reduced [Ca2+]cyt. In addition, TREK1 knockdown downregulated the gene expression of collage type I and platelet-derived growth factor. Furthermore, TREK1 knockdown inhibited the proliferation of LX-2 cells. In conclusion, the activity of TREK1 channels determines the resting membrane potential and [Ca2+]cyt, which play a role in extracellular matrix production and cell proliferation in HSCs. This study may help elucidate the molecular mechanism underlying hepatic fibrosis in HSCs and provide a potential therapeutic target for hepatic fibrosis.
- Published
- 2022